Trifluoperazine 2HCl: Potent Dopamine D2 Receptor Inhibitor for Neuropharmacology and Immunology Research

Executive Summary: Trifluoperazine 2HCl is a phenothiazine derivative with an IC50 of 1.1 nM against the dopamine D2 receptor, offering robust inhibition for dopaminergic signaling research (APExBIO). The compound exhibits high solubility in DMSO (≥24.02 mg/mL), water (≥48 mg/mL), and ethanol (≥7.26 mg/mL, ultrasonic-assisted), supporting diverse in vitro and in vivo protocols. Phenothiazines, including Trifluoperazine, induce autophagy and ROS in macrophages, enhancing antibacterial defense (Qiu et al., 2025). Trifluoperazine 2HCl is widely cited in neuropharmacology, immunology, and oncology research for its mechanistic specificity and reproducibility. Proper storage at -20°C and the use of freshly prepared solutions are essential for experimental reliability (APExBIO).

Biological Rationale

Trifluoperazine 2HCl is a research-grade phenothiazine, chemically known as 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine dihydrochloride. The compound’s primary biological target is the dopamine D2 receptor, a G protein-coupled receptor central to dopaminergic signaling in the CNS (APExBIO). Dysregulation of dopamine D2 receptors is implicated in neurological disorders including schizophrenia and Parkinson’s disease (Trifluoperazine 2HCl (SKU B1397): Optimizing Dopaminergic...). This article extends prior guides by detailing immunomodulatory effects and ROS/autophagy induction in macrophages—mechanisms not covered in earlier workflow articles. Trifluoperazine 2HCl’s utility extends to cancer biology, particularly in medulloblastoma models, and to immunological studies focused on host-pathogen interaction (Qiu et al., 2025).

Mechanism of Action of Trifluoperazine 2HCl

Trifluoperazine 2HCl acts as a competitive antagonist at the dopamine D2 receptor, with a reported IC50 of 1.1 nM in radioligand binding assays (APExBIO). This high affinity enables selective inhibition of dopaminergic signaling pathways, allowing precise modulation in neuropharmacology assays. The phenothiazine scaffold also enables secondary pharmacological effects, notably the induction of autophagy and reactive oxygen species (ROS) in macrophages (Qiu et al., 2025). Upon cellular uptake, Trifluoperazine 2HCl promotes lysosomal activity, facilitating autophagic flux and ROS accumulation. These mechanisms enhance antibacterial responses in host immune cells without directly targeting pathogens, distinguishing it from conventional antibiotics.

Evidence & Benchmarks

• Trifluoperazine 2HCl inhibits dopamine D2 receptor-mediated signaling with an IC50 of 1.1 nM, validated in competitive binding assays (APExBIO).
• Phenothiazines, including Trifluoperazine, induce autophagy and ROS in murine macrophages, enhancing clearance of intracellular Salmonella Typhimurium (Qiu et al., 2025).
• Co-treatment with autophagy inhibitors or ROS scavengers abrogates the antibacterial effect, confirming mechanistic specificity (Qiu et al., 2025).
• Trifluoperazine 2HCl demonstrates high solubility: ≥24.02 mg/mL in DMSO, ≥48 mg/mL in water, and ≥7.26 mg/mL in ethanol (ultrasonicated), supporting in vitro and in vivo protocols (APExBIO).
• Freshly prepared solutions and -20°C storage are required for optimal stability and reproducibility in experimental settings (APExBIO).

Applications, Limits & Misconceptions

Trifluoperazine 2HCl is widely used in neuroscience, immunology, and oncology. Its primary application is as a dopamine D2 receptor antagonist for research into dopaminergic signaling and neurological disorders (Trifluoperazine 2HCl (SKU B1397): Reliable Solutions for ...). This article clarifies how immunomodulatory mechanisms—particularly autophagy and ROS induction—expand its utility beyond prior neuropharmacology-focused reviews. In immunology, Trifluoperazine 2HCl is a tool for dissecting host-directed antibacterial strategies and macrophage activation. In cancer research, it supports therapeutic screening, notably in medulloblastoma models.

Common Pitfalls or Misconceptions

• Trifluoperazine 2HCl is not a direct antibiotic; its antibacterial effects are mediated via host cell modulation, not direct bacterial inhibition (Qiu et al., 2025).
• Long-term storage of prepared solutions at room temperature results in decreased potency; always prepare fresh solutions and store stocks at -20°C (APExBIO).
• Not all effects are dopamine receptor–dependent; off-target actions (e.g., on calmodulin) may occur at higher concentrations (Trifluoperazine 2HCl: A Translational Powerhouse...).
• IC50 values are assay- and cell-type dependent; always contextualize reported potency with experimental details.
• Use in vivo requires rigorous pharmacokinetic assessment due to species-specific metabolism and blood–brain barrier considerations.

Workflow Integration & Parameters

Trifluoperazine 2HCl (SKU B1397) from APExBIO is supplied as a solid with a molecular weight of 480.42 and formula C21H24F3N3S·2HCl (product page). For cell-based assays, dissolve at ≥24.02 mg/mL in DMSO or ≥48 mg/mL in water. Prepare working solutions freshly to avoid degradation. Store solid at -20°C, protected from light. For in vitro neuropharmacology, use concentrations ranging from 0.1 nM to 10 μM, titrated according to cell type and desired inhibition. In immunological studies, dose-response curves should be established for autophagy/ROS endpoints. For translational workflows, reference validated protocols as outlined in Trifluoperazine 2HCl: Expanding Neuropharmacology and Imm...—this article updates the systems biology perspective with new mechanistic details and workflow optimizations.

Conclusion & Outlook

Trifluoperazine 2HCl is a validated, high-affinity dopamine D2 receptor antagonist with extended utility in immune modulation and cancer biology. Its robust chemical profile and mechanistic specificity support reproducible results across dopaminergic signaling, autophagy, and ROS induction studies. Future research should further delineate off-target actions and optimize translational protocols for in vivo models. For detailed product specifications and sourcing, consult the APExBIO Trifluoperazine 2HCl page.